Cite
TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease.
MLA
Melo, Miguel, et al. “TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease.” The Journal of Clinical Endocrinology and Metabolism, vol. 102, no. 6, June 2017, pp. 1898–907. EBSCOhost, https://doi.org/10.1210/jc.2016-2785.
APA
Melo, M., Gaspar da Rocha, A., Batista, R., Vinagre, J., Martins, M. J., Costa, G., Ribeiro, C., Carrilho, F., Leite, V., Lobo, C., Cameselle-Teijeiro, J. M., Cavadas, B., Pereira, L., Sobrinho-Simões, M., & Soares, P. (2017). TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease. The Journal of Clinical Endocrinology and Metabolism, 102(6), 1898–1907. https://doi.org/10.1210/jc.2016-2785
Chicago
Melo, Miguel, Adriana Gaspar da Rocha, Rui Batista, João Vinagre, Maria João Martins, Gracinda Costa, Cristina Ribeiro, et al. 2017. “TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease.” The Journal of Clinical Endocrinology and Metabolism 102 (6): 1898–1907. doi:10.1210/jc.2016-2785.